GL Pharm Tech Corporation
15 clinical trials · Sponsor
◉ Watch GL Pharm Tech Corporation
| Record | Firm | Date |
|---|---|---|
| Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of GLH8NDE in Patients With Dry Eye Disease (NCT04679883) | GL Pharm Tech Corporation | 2021-04-01 |
| A Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of GLH8NDE After Single and Mutiple Ocular Administrations in Healthy Korean and Caucasian Volunteers (NCT04104997) | GL Pharm Tech Corporation | 2019-09-26 |
| The Pharmacokinetics of GLA5PR Tablet According to the Renal Function (NCT03963362) | GL Pharm Tech Corporation | 2019-09-17 |
| Pharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers(Fed) (NCT03927170) | GL Pharm Tech Corporation | 2019-05-02 |
| Pharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers (NCT03851341) | GL Pharm Tech Corporation | 2019-01-02 |
Track GL Pharm Tech Corporation automatically
Every clearance here is in the API, with alerts when new ones post.